ArticleNPJ Regenerative medicine2025

Preclinical efficacy and safety of AAVrh10-based plakophilin-2 gene therapy (LX2020) as a treatment for arrhythmogenic cardiomyopathy.

Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.